|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Danish Headache Center |
|---|---|
| Information provided by: | Danish Headache Center |
| ClinicalTrials.gov Identifier: | NCT00363571 |
Purpose
After infusion / injection of Glyceryl trinitrate and Diamox it is wished to study the effect of drugs on the cerebral haemodynamics such as Cerebral blod flow and cerebral blod volume.
| Condition | Intervention |
|---|---|
|
Migraine |
Drug: GTN, Diamox |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double-Blind Primary Purpose: Educational/Counseling/Training |
| Official Title: | The Effect of Glyceryl Trinitrate (GTN) and Diamox on Cerebral Haemodynamics Judged With the Help of 3-Tesla MRI. |
| Estimated Enrollment: | 12 |
| Study Start Date: | August 2006 |
| Estimated Study Completion Date: | May 2007 |
Experimental headache model open a unike opportunity to study the pathophysiological mechanisms behind headache in general and migrane in particular. Previous studies have used various techniques to study the cerebral haemodynamics as a basis for the headache pathophysiology. We wish to use a 3-Tesa MRI so study the cerebral haemodynamics after application of various pharmacological substances.
The most used experimental headache model is the glyceryl trinitrate model (GTN). Where infusion of the NO donor GTN induces headache and changes in the cerebral arteries. On the other hand injection of Diamox (Acetazolamide) apparently causes increase of the cerebral blod flow with out dilation of the arteries. We wish to study the precise effect of GTN and diamox on the cerebral haemodynamics such as Cerebral blod flow (CBF) and Cerebral blod volume (CBV) via a 3-Tesla MRI.
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Mohammad Sohail Asghar, MD | +4543232161 | asgsoh01@glostruphosp.kbhamt.dk |
| Denmark | |
| Danish Headache Center, Neurological Dep. Glostrup hospital | |
| Glostrup, Denmark, 2770 | |
| Study Chair: | Messoud Ashina, MD,Ph.D | Danish Headache Center |
More Information
| ClinicalTrials.gov Identifier: | NCT00363571 History of Changes |
| Other Study ID Numbers: | KA-20060084 |
| Study First Received: | August 14, 2006 |
| Last Updated: | August 14, 2006 |
| Health Authority: | Denmark: The Danish National Committee on Biomedical Research Ethics |
|
Migraine Disorders Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Acetazolamide Anticonvulsants Central Nervous System Agents |
Therapeutic Uses Pharmacologic Actions Carbonic Anhydrase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Diuretics Natriuretic Agents Physiological Effects of Drugs Cardiovascular Agents |